Multiple Sclerosis

Multiple sclerosis (MS) is a severe autoimmune disease of the central nervous system that affects the brain and spinal cord, causing problems with muscle movement, balance and vision.

Multiple Sclerosis (MS)

Multiple sclerosis (MS) is a neurodegenerative disorder that damages the nerves in the brain and spinal cord, leading to problems with muscle movement, balance and vision.

Multiple sclerosis and smoking

Types of Multiple Sclerosis (MS)

Working Towards Earlier Diagnosis of Multiple Sclerosis

Benign Multiple Sclerosis (MS)

Multiple Sclerosis in Children

Anti-Myelin Antibodies in Multiple Sclerosis

Remyelination Strategies for Multiple Sclerosis

Epigenetics for Multiple Sclerosis

Multiple Sclerosis Epidemiology

See more featured articles »

Relapsing-Remitting Multiple Sclerosis (RRMS)

Multiple Sclerosis and Pregnancy

Secondary Progressive Multiple Sclerosis (SPMS)

Multiple sclerosis and beta interferon

Primary Progressive Multiple Sclerosis (PPMS)

How is RRMS Different from PPMS and SPMS?

What Causes Multiple Sclerosis?

Cognitive Impairment and Multiple Sclerosis

Heat Intolerance in Multiple Sclerosis

At-Home Physiotherapy Exercises for Multiple Sclerosis

Multiple Sclerosis and Women’s Health

Optic Neuritis and Multiple Sclerosis

Early Signs of Multiple Sclerosis

Latest Multiple Sclerosis News and Research

Researchers decipher anti-MOG antibody construction, paving way for therapies

MOG Antibody-associated Disease (MOGAD) is a rare autoimmune disease of the central nervous system. The blood of patients contains antibodies against myelin oligodendrocyte glycoprotein (MOG), a protein in the myelin layer that surrounds the neurons in the brain. It is believed that these antibodies contribute to the destruction of this protective layer in the brain.

18 Dec 2025

Eating high-fat cheese and cream may be linked to lower dementia risk

Eating more high-fat cheese and high-fat cream may be linked to a lower risk of developing dementia, according to a new study published on December 17, 2025, in Neurology, the medical journal of the American Academy of Neurology.

17 Dec 2025

Study finds small sex differences in recovery after ischemic stroke

When examining recovery during the first year after an ischemic stroke, a new study has found for daily tasks such as eating, dressing and driving, female participants experienced slightly worse recovery than male participants.

17 Dec 2025

Genetic differences can affect the effectiveness of antibody therapies

The genome differs from person to person in thousands of positions. In some cases, this means that proteins have a different building block in certain regions, rendering some antibody-based therapies ineffective, report researchers from the University of Basel, Switzerland.

17 Dec 2025

Distant astrocytes found to play a key role in spinal cord repair

Cedars-Sinai investigators have discovered a healing mechanism that could one day be harnessed to help treat patients with spinal cord injuries, stroke, and neurological conditions such as multiple sclerosis.

17 Dec 2025

Lipoic acid shows limited benefit in progressive multiple sclerosis

The over-the-counter supplement lipoic acid may have a small beneficial effect in slowing the loss of gray matter in the brains of people with progressive forms of multiple sclerosis, according to new research led by Oregon Health & Science University and the Portland VA Health Care System.

15 Dec 2025

Gut bacteria mimicry can accelerate the progression of multiple sclerosis

If gut bacteria are too similar to the protective layer of nerves, they can misdirect the immune system and cause it to attack its own nervous system.

15 Dec 2025

Autoimmune attack on CASPR2 drives nerve hyperexcitability and involuntary muscle activity

A scientific review on autoimmune neurological diseases reveals what occurs in our body when the immune system, by mistake, produces antibodies that target a protein essential for the normal functioning of nerves.

12 Dec 2025

Researchers identify enzyme linked to myelin damage and neurodegenerative conditions

Researchers at Oregon Health & Science University have identified a type of enzyme with a complicated name - cell migration inducing and hyaluronan-binding protein, or CEMIP - is associated with disorders ranging from multiple sclerosis to stroke to neurodegenerative conditions like Alzheimer's disease.

11 Dec 2025

Missing piece of myelin results in slower, less consistent signal transmission to the brain

Our nerve cells are surrounded by a protective layer (myelin). This protective layer allows signals to pass between cells incredibly quickly.

11 Dec 2025

Glucose-lowering drugs may reduce risk of developing epilepsy

A preliminary study of people with diabetes suggests that use of glucose-lowering GLP-1 drugs may be linked to a lower risk of developing epilepsy. The study was published on December 10, 2025, in Neurology, the medical journal of the American Academy of Neurology.

10 Dec 2025

New AAN guideline offers treatment strategies for functional seizures

To help neurologists, mental health clinicians and other clinicians determine the best ways to help people manage functional seizures, the American Academy of Neurology has issued a new guideline, published on December 10, 2025, in Neurology, the medical journal of the American Academy of Neurology.

10 Dec 2025

Machine learning models can help diagnose ALS earlier from a blood sample

Using machine learning models, researchers at Michigan Medicine have identified a potential way to diagnose amyotrophic lateral sclerosis, or ALS, earlier from a blood sample, a study suggests.

10 Dec 2025

Poor kidney function associated with elevated Alzheimer’s markers in the blood

People with impaired kidney function have higher levels of Alzheimer's biomarkers in their blood, but not an increased risk of dementia, according to a study published December 3, 2025, in Neurology®, the medical journal of the American Academy of Neurology.

3 Dec 2025

They need a ventilator to stay alive. Getting one can be a nightmare.

On vacation in Mexico last year, Michael DiPlacido passed out twice while scuba diving and again in his hotel. Back in St. Louis, doctors diagnosed him with amyotrophic lateral sclerosis, or ALS, an incurable disease that often requires mechanical ventilation.

2 Dec 2025

RFK Jr. wants to delay the hepatitis B vaccine. Here’s what parents need to know.

Working out of a tribal-owned hospital in Anchorage, Alaska, liver specialist Brian McMahon has spent decades treating the long shadow of hepatitis B. Before a vaccine became available in the 1980s, he saw the virus claim young lives in western Alaskan communities with stunning speed.

2 Dec 2025

Towering 'body-swap' robot exposes the brain’s strategy for staying upright

What if a robot could show us how the brain keeps us balanced? UBC scientists built one – and their discovery could help shape new ways to reduce fall risk for millions of people.

27 Nov 2025

Driving behavior data may help detect early cognitive decline

Using in-vehicle driving data may be a new way to identify people who are at risk of cognitive decline, according to a study published on November 26, 2025, in Neurology, the medical journal of the American Academy of Neurology.

26 Nov 2025

New analysis shows one in two people in the U.S. live with neurological conditions

One in two people in the United States, just over half of the population, is affected by a neurological disease or disorder, according to a new systematic analysis by the American Academy of Neurology and the Institute for Health Metrics and Evaluation published on November 24, 2025, in the journal JAMA Neurology.

24 Nov 2025

Does coffee truly boost memory and focus or is it all hype?

Coffee’s bioactive compounds, especially caffeine, show potential cognitive, neuroprotective, and neuroplasticity benefits across animal and human studies. However, most findings are observational, mechanisms remain uncertain, and optimal intake is still unclear.

23 Nov 2025